2:VP2

1
??????? 2VP2 ????? ????? ????? ??? ???? ???????
????? ?????? ?????
2
??????? 2
??????
??????
3
VP2
???? ???????
??????? ??????
RNA
VP3
VP1
?? ???
????? ???????
?? ???? ??? ????
4
?????? ???? ????? ??????? 2
????? ?????
???? ????? ?????? VP2
RNA
DNA
VP2
????? ????? ???? ????? ?? ?????
???? ?????? ?? VP2
????? ?????
??????? 2
???? ????? ?? VP2
5
VP2
??????? 2
????? VP2
??????? ??????? ? VP2
VP2
RNA
????? ???? ???????
VP3
VP1
6
???? ???? ?????
Protection Bursal AGP Negative after
challenge
Trial 2
Trial 3
Trial 1
70
73
91
???????
1/12
4/15
6/20
??????? 2
95
93
98
1/14
1/15
1/20
0 mortality in challenged groups
7
??????? 2 ????? ???
????
93
(AGP-NEG)
????? 0
8
??? ??? ??? ??????? ? AGP ????? ???? ?????
???????? 2 ????
????? ????? ????? ???? ?? ??????
????
AGP
(AGP-NEG)
100
85-93
50
0 mortality
9
?????
????? ???????? 2 ?????? ???????? ?? ????? ?????
??? ?????? ?????? ? 300 ?????? ????? ????? ????
??????.
????? ???????? 2 ????? ????? ????? ????? ????
?????? ????? ???? ????? ????? ??????? ???????
???? ?????? ?? ????? ??????? ?????? ???? ?????